132 related articles for article (PubMed ID: 16534510)
21. Serum and semen prostate specific antigen concentrations are different in young spinal cord injured men compared to normal controls.
Lynne CM; Aballa TC; Wang TJ; Rittenhouse HG; Ferrell SM; Brackett NL
J Urol; 1999 Jul; 162(1):89-91. PubMed ID: 10379747
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
23. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men?
Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M
Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
25. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.
Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T
Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393
[TBL] [Abstract][Full Text] [Related]
26. Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens.
Lotan TL; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1360-6. PubMed ID: 18670353
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
Morgentaler A; Rhoden EL
Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
[TBL] [Abstract][Full Text] [Related]
29. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
[TBL] [Abstract][Full Text] [Related]
30. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience.
Soloway MS; Soloway CT; Williams S; Ayyathurai R; Kava B; Manoharan M
BJU Int; 2008 Jan; 101(2):165-9. PubMed ID: 17850361
[TBL] [Abstract][Full Text] [Related]
31. Autonomic function following cervical spinal cord injury.
Krassioukov A
Respir Physiol Neurobiol; 2009 Nov; 169(2):157-64. PubMed ID: 19682607
[TBL] [Abstract][Full Text] [Related]
32. Spinal cord injury and cholelithiasis.
Xia CS; Han YQ; Yang XY; Hong GX
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):595-8. PubMed ID: 15567753
[TBL] [Abstract][Full Text] [Related]
33. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM; Banu E; Oudard S
BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
[TBL] [Abstract][Full Text] [Related]
35. Hematologic abnormalities within the first week after acute isolated traumatic cervical spinal cord injury: a case-control cohort study.
Furlan JC; Krassioukov AV; Fehlings MG
Spine (Phila Pa 1976); 2006 Nov; 31(23):2674-83. PubMed ID: 17077735
[TBL] [Abstract][Full Text] [Related]
36. Lower urinary tract symptoms and risk of prostate cancer in Japanese men.
Matsubara A; Yasumoto H; Teishima J; Seki M; Mita K; Hasegawa Y; Yoshino T; Kato M; Usui T
Int J Urol; 2006 Aug; 13(8):1098-102. PubMed ID: 16903936
[TBL] [Abstract][Full Text] [Related]
37. Prostate size and PSA serum levels in male patients with spinal cord injury.
Pannek J; Berges RR; Cubick G; Meindl R; Senge T
Urology; 2003 Nov; 62(5):845-8. PubMed ID: 14624906
[TBL] [Abstract][Full Text] [Related]
38. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor and interleukin-6 in combination with prostate volume are possible prostate cancer tumor markers in patients with gray-zone PSA levels.
Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Namba Y; Kishikawa H; Takahara S; Ichikawa Y
Prostate Cancer Prostatic Dis; 2008; 11(3):258-63. PubMed ID: 17876341
[TBL] [Abstract][Full Text] [Related]
40. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
Krejcarek SC; Chen MH; Renshaw AA; Loffredo M; Sussman B; D'Amico AV
Urology; 2007 Mar; 69(3):515-9. PubMed ID: 17382156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
